30 April 2007

Black cohosh may cut cancer risk

Women taking supplements of black cohosh may cut their risk of breast cancer by more than 50 percent, suggests an epidemiological study from the US.

Women taking supplements of black cohosh may cut their risk of breast cancer by more than 50 percent, suggests an epidemiological study from the US.

The study, published in the International Journal of Cancer, needs significant support from future studies before it can be recommended as a breast cancer preventative, but the research could offer a new avenue of research for the herb most commonly used by women to reduce menopausal symptoms such as hot flushes.

Popular alternative to HRT
Black cohosh (referred to by the European Medicines Agency, or EMEA, as Cimicifugae racemosae rhizome) is a member of the buttercup family, and is a perennial plant native to North America.

Historically it has been a popular alternative to hormone replacement therapy (HRT) in many countries including the UK, where it is estimated that 9 million days worth of black cohosh supplements were purchased in 2004.

"Hormone-related supplements (HRS), many of which contain phytoestrogens, are widely used to manage menopausal symptoms, yet their relationship with breast cancer risk has generally not been evaluated," explained lead author Timothy Rebbeck from University of Pennsylvania School of Medicine.

How the study was done
The researchers used a population-based case-control study consisting of 949 breast cancer cases and 1 524 controls. Demographic information and the use of hormone-related supplements were identified using questionnaires.

Rebbeck and co-workers report that herbal use was more prevalent among African American women than European American women (19.2 versus 14.7, respectively), as well as specific preparations including red clover (4.7 versus 0.6 percent), black cohosh (5.4 versus 2.0 percent), and ginseng (12.5 versus 7.9 percent, respectively).

After adjusting for potential confounding factors, the use of black cohosh was associated with a 61 percent reduction in the risk of breast cancer, said the researchers. This risk reduction was also observed for Remifemin, a herbal preparation derived from black cohosh, which was calculated to reduce the risk of breast cancer by 53 percent.

More research needed
"Substantial additional research must be undertaken before it can be established that black cohosh, or some compound found in black cohosh, is a breast cancer chemopreventive agent," wrote the researchers.

"Furthermore, women may wish to seek guidance from their physician before using these compounds," they concluded.

Previously, concerns have been raised about breast cancer patients taking black cohosh supplements in order to alleviate the menopause-like side effects. Researchers from Yale School of Medicine reported that black cohosh might interact detrimentally with chemotherapy by increasing cytotoxicity (cell killing) by two of the drugs, doxorubicin and docetaxel. It decreased the cytotoxicity of cisplatin.

Over one million women worldwide are diagnosed with breast cancer every year, with the highest incidences in the US and the Netherlands. China has the lowest incidence and mortality rate of the disease. - (Decision News Media, April 2007)

Read more:
Black cohosh fails test
How black cohosh cools hot flushes


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Mental health & your work »

How open are you about mental illness in the workplace?

Mental health in the workplace – what you can do to help

If you know that one of your colleagues suffers from a mental illness, would you be able to help them at work? Maligay Govender offers some helpful mental health "first aid" tips.

Sleep & You »

Sleep vs. no sleep Diagnosis of insomnia

6 things that are sabotaging your sleep

Kick these shut-eye killers to the kerb and make your whole life better – overnight.